Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

120 results about "Single mutation" patented technology

Single gene Mutations. (a) Mutations are random changes in the genome that can result in no protein or an altered protein being expressed. (b) Single gene mutations involve the alteration of a DNA nucleotide sequence as a result of the substitution, insertion or deletion of nucleotides.

Mutant protein screening method and device and related equipment

The invention discloses a mutant protein screening method and device and related equipment thereof, and relates to the technical field of material determination and analysis. The method comprises the following steps: respectively carrying out simulated single mutation on a plurality of amino acid sites in a protein sequence of a target protein to obtain a plurality of simulated mutant proteins, and determining adaptability evaluation values F of the plurality of simulated mutant proteins based on a target protein language model; determining structural stability values S of the plurality of simulated mutant proteins based on a protein folding energy calculation tool; performing normalization processing on the adaptability evaluation value F and the structural stability value S, and performing single-index sorting and comprehensive-index sorting on normalization processing results; and screening the plurality of simulated mutant proteins according to the target screening number, the single index sorting result and the comprehensive index sorting result to obtain a target mutant protein. According to the method, the protein design transformation difficulty can be reduced, the mutant protein screening effect is improved, the calculation amount required by protein transformation and screening is reduced, and the consumption cost is reduced.
Owner:CIXI INST OF BIOMEDICAL ENG NINGBO INST OF IND TECH CHINESE ACAD OF SCI NINGBO +1

Tyrosine phenol lyase mutant and application thereof in synthesis of tyrosine derivative

The invention discloses a tyrosine phenol lyase mutant and application of the tyrosine phenol lyase mutant in synthesis of a tyrosine derivative. The mutant is obtained by performing single mutation or multiple mutation on the 18th site or the 417th site of an amino acid sequence shown in SEQ ID NO.2. Compared with a wild type, the tyrosine phenol lyase mutant provided by the invention has more excellent enzyme activity and more excellent catalytic performance. According to the TPL mutant, the cumulative concentration for synthesizing levodopa is up to 160 g / L or above, the cumulative concentration for synthesizing L-tyrosine is up to 80 g / L or above, the cumulative concentration for synthesizing 3, 4, 5-TOPA is up to 16.4 g / L or above, the cumulative concentration for synthesizing 3-fluoro-L-tyrosine is up to 33.1 g / L or above, the cumulative concentration for synthesizing 2-fluoro-L-tyrosine is up to 20.5 g / L or above, and the optical purity is greater than 99.9%.
Owner:ZHEJIANG UNIV OF TECH

Tagolose-4-epimerase mutant and application thereof

The invention belongs to the field of biological pharmacy and biotransformation, and particularly relates to a tagatose-4-epimerase mutant and application thereof. The tagatose-4-epimerase mutant disclosed by the invention is obtained by carrying out single mutation or combined mutation on an amino acid residue at a specific position of an amino acid sequence as shown in SEQ ID NO.1. Compared with wild type tagatose-4-epimerase, the mutant has the advantage that the catalytic activity is improved when the D-tagatose is prepared through conversion. The obtained tagatose-4-epimerase mutant has the advantages of being mild in reaction condition, green, environmentally friendly, single in product and easy to separate and purify, and the production cost is greatly reduced.
Owner:ZHEJIANG UNIV OF TECH +1

Streptomyces-derived cytochrome P450 enzyme mutant and application thereof in synthesis of ursodesoxycholic acid

The invention discloses a streptomyces-derived cytochrome P450 enzyme mutant and an application of the streptomyces-derived cytochrome P450 enzyme mutant in synthesis of ursodesoxycholic acid. The cytochrome P450 enzyme mutant is obtained by carrying out single mutation or multiple mutation on the 181st site, the 192nd site, the 249th site or the 288th site of an amino acid sequence shown in SEQ ID NO.2. The cytochrome P450 enzyme mutant has high activity and regioselectivity, low-cost lithocholic acid is used as a substrate, efficient cytochrome P450 enzyme is used for hydroxylating the 7beta site of the lithocholic acid, ursodesoxycholic acid is synthesized in one step, the industrial production cost is greatly reduced, and the cytochrome P450 enzyme mutant has good application prospects in industrial production of ursodesoxycholic acid.
Owner:ZHEJIANG UNIV OF TECH

3-ketosteroid-delta1-dehydrogenase mutant and application thereof in preparation of steroid drug intermediate

The invention discloses a 3-sterone-delta1-dehydrogenase mutant and application of the 3-sterone-delta1-dehydrogenase mutant in preparation of a steroid drug intermediate. The mutant is obtained by performing single mutation or multiple mutation on 551, 468, 48 and 157 sites of an amino acid sequence of 3-sterone-delta1-dehydrogenase as shown in SEQ ID NO: 1. The 3-ketosterone-delta1-dehydrogenase is subjected to molecular modification through directed evolution and semi-rational design, the mutant with improved enzyme activity is screened in a high-throughput mode, the mutant can effectively improve the conversion rate of a substrate 11alpha, 17alpha-dihydroxyprogesterone, and the substrate conversion rate of the mutant ISM-2 is improved to 92.4% compared with 36.7% before mutation.
Owner:ZHEJIANG UNIV OF TECH

L-aspartate transaminase mutant and application thereof

The invention discloses an L-aspartic acid transaminase mutant and application thereof. The L-aspartic acid transaminase mutant is obtained by performing single mutation on the 104th amino acid of the amino acid sequence of L-aspartic acid transaminase. The L-aspartic acid transaminase mutant is used for synthesizing an L-phenylglycine derivative. The L-aspartic acid transaminase mutant is from escherichia coli, homologous sequence analysis and molecular docking simulation are carried out, site-specific mutagenesis verification is combined, and single-point mutation is carried out on the 104 amino acid to obtain the T104S mutant. The L-aspartic acid transaminase mutant disclosed by the invention can be used for efficiently catalyzing to generate an L-phenylglycine derivative, and compared with a wild type, the specific activity of the T104S mutant to o-chlorophenoxyacetic acid is 3.2 times that of the wild type.
Owner:HEFEI UNIV OF TECH

Tagolose-4-epimerase mutant, coding gene and application

The invention belongs to the field of biological pharmacy and biotransformation, and particularly relates to a tagatose-4-epimerase mutant, a coding gene and application. The tagatose-4-epimerase mutant disclosed by the invention is obtained by carrying out single mutation or combined mutation on an amino acid residue at a specific position of an amino acid sequence as shown in SEQ ID NO.1. Compared with wild type tagatose-4-epimerase, the mutant has the advantage that the catalytic activity is improved when the D-tagatose is prepared through conversion. The obtained tagatose-4-epimerase mutant has the advantages of being mild in reaction condition, green, environmentally friendly, single in product and easy to separate and purify, and the production cost is greatly reduced.
Owner:ZHEJIANG UNIV OF TECH +1

High-temperature-resistant D-psicose-3-epimerase mutant and application thereof in preparation of D-psicose

The invention discloses a high-temperature-resistant D-psicose-3-epimerase mutant and application of the high-temperature-resistant D-psicose-3-epimerase mutant in preparation of D-psicose. The mutant is obtained by performing single mutation or multiple mutations on the 17th site, the 118th site, the 121st site, the 165 site, the 197th site and the 249th site of an amino acid sequence shown in SEQ ID NO.2. The invention further discloses a preparation method of the high-temperature-resistant D-psicose-3-epimerase mutant. The mutant obtained through screening can tolerate the high temperature of 45-70 DEG C, the Tm value of the mutant enzyme is increased, the half-life period of the enzyme is prolonged, the affinity and conversion efficiency of the enzyme to a substrate D-psicose are improved, a relatively rare enzyme library is expanded, then the production cost is reduced, and the industrial application value of the D-psicose-3-epimerase is further improved.
Owner:ZHEJIANG UNIV OF TECH

Tagolose-4-epimerase mutant as well as coding gene and application thereof

The invention belongs to the field of biological pharmacy and biotransformation, and particularly relates to a tagatose-4-epimerase mutant as well as a coding gene and application thereof. The tagatose-4-epimerase mutant disclosed by the invention is obtained by carrying out single mutation or combined mutation on an amino acid residue at a specific position of an amino acid sequence as shown in SEQ ID NO.1. Compared with wild type tagatose-4-epimerase, the mutant has the advantage that the catalytic activity is improved when the D-tagatose is prepared through conversion. The obtained tagatose-4-epimerase mutant has the advantages of being mild in reaction condition, green, environmentally friendly, single in product and easy to separate and purify, and the production cost is greatly reduced.
Owner:ZHEJIANG UNIV OF TECH +1

Compact genome editor and base editor based on IscB system and application of compact genome editor and base editor

The invention provides a genome editor enDelIscB and a genome editor enDelIscB-T5E based on an IscB system, and further provides a base editor ICBE and a base editor IABE based on the enDelIscBD60A. According to the invention, a genome editor and a base editor which are more compact in size and higher in cleavage activity and insertion / deletion efficiency are realized by optimizing a single mutation site of the activity of a DelIscB protein cleavage plasmid, an optimized variant of the DelIscB protein and an optimized sgRNA variant of the DelIscB. According to the present invention, it is verified that the albinism model is efficiently constructed by using the enDelIscB editor and the enDelIscB-T5E editor through micro-injection of the mouse embryo, such that the enDelIscB editor and the enDelIscB-T5E editor have great potential in the field of genome editing.
Owner:INSTITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES

D-psicose invertase mutant and application thereof

The invention discloses a D-psicose invertase mutant and application thereof. The mutant is obtained by performing single mutation or multiple mutation on the 13th site, the 49th site, the 54th site, the 100th site, the 235th site and the 242th site of an amino acid sequence shown in SEQ ID NO.2. The invention further discloses a preparation method of the D-psicose invertase mutant. The D-psicose invertase mutant can tolerate the high temperature of 40-80 DEG C, the half-life period of the mutant enzyme is prolonged, the substrate affinity and conversion efficiency of the enzyme to D-fructose used as a substrate for synthesizing D-psicose are improved, a relatively rare enzyme library is expanded, and the D-fructose is green, environment-friendly, low in toxicity and high in yield when being used for synthesizing the D-psicose invertase. The method overcomes the problem that three wastes are easily generated in a chemical synthesis method, and has important industrial application prospects.
Owner:ZHEJIANG UNIV OF TECH

DsPETase01 plastic degrading enzyme mutant and application thereof

The invention discloses a dsPETase01 plastic degrading enzyme mutant and application thereof, and relates to the technical field of bioengineering, the amino acid sequence of a wild type plastic degrading enzyme (dsPETase01) is designed and modified, 8 dsPETase01 single mutation sites or 19 combined mutation sites are provided, the thermal stability of the obtained dsPETase01 mutant is improved by about 4-21 DEG C compared with that of the wild type dsPETase01, and the dsPETase01 mutant can be used for preparing a plastic degrading enzyme. And the activity is improved by nearly 1.2-3 times. The invention also provides four preferable mutant proteins which have higher yield, activity and thermal stability compared with wild dsPETase01, have wider application conditions, are more suitable for degrading PET (Polyethylene Terephthalate) plastics, and are beneficial to large-scale production and industrial application.
Owner:BIORTUS BIOSCI +1

Application of phospholipase D mutant in biosynthesis of phosphatidylserine

The invention provides a phospholipase D mutant and application thereof, compared with an amino acid sequence SEQ ID NO.2, four sites of Y6570, D6595, R6661 and D6669 in the amino acid sequence SEQ ID NO.2 are respectively subjected to single mutation, pairwise combined mutation, three combined mutation or one of four combined mutation; the novel phospholipase D mutant industrial enzyme is used for synthesizing and preparing L-phosphatidylserine. The phospholipase D mutant enzyme constructed by the invention has the characteristics of low enzyme cost, short conversion time, simple process operation and the like, and has a wide prospect of large-scale industrial application.
Owner:GUANGDONG SHENGSHI HERBAL BIOTECHNOLOGY CO LTD

Nitrilase mutant and application thereof in amide synthesis

The invention discloses construction and application of a novel nitrilase with improved amide generation capability and a mutant thereof. The amino acid sequence of the nitrilase disclosed by the invention is as shown in SEQ ID NO: 1, and the mutant of the nitrilase is obtained by performing single mutation on the 51st site, the 162nd site and the 185th site of the sequence as shown in SEQ ID NO: 1. The nitrilase provided by the invention has excellent amide generation capability, and has important industrial application potential for green and efficient preparation of amide compounds.
Owner:BAI KAISHENG (SHANGHAI) BIOTECHNOLOGY CO LTD

Glucose dehydrogenase GOX-2015 mutant and application thereof

The invention discloses a glucose dehydrogenase GOX-2015 mutant and application thereof, and relates to the technical field of bioengineering, the amino acid sequence of wild type glucose dehydrogenase GOX-2015 is designed and modified, that is, 18 single mutation sites and 16 combined mutation sites are provided, and the glucose dehydrogenase GOX-2015 mutant is obtained. Compared with the wild type GOX-2015, the thermal stability of the obtained GOX-2015 mutant is improved by about 2 to 13 DEG C, and the activity of the obtained GOX-2015 mutant is improved by about 1.2 to 4.5 times. The invention further provides a preferable mutant protein which has higher yield, activity and thermal stability compared with wild type GOX-2015, has wider application conditions, is more suitable for efficient production of NADPH coenzyme by a biological conversion method, and is beneficial to large-scale production and industrial application.
Owner:BIORTUS BIOSCI +1

Artificial intelligence-based enzyme engineering method and system, device, and medium

PCT designated stageWO2026061352A1ProteomicsGenomicsSingle mutationWild type
The present invention relates to the technical field of enzyme engineering. Disclosed are an artificial intelligence-based enzyme engineering method and system, a device, and a medium. The method comprises: on the basis of structural information of an engineered enzyme to be modified, using an inverse protein folding model to obtain a plurality of structurally compatible protein sequences on the basis of a given scaffold structure; on the basis of the plurality of structurally compatible protein sequences, obtaining a mutant amino acid frequency and a wild-type amino acid frequency at each sequence position; and on the basis of the mutant amino acid frequency and the wild-type amino acid frequency at each sequence position and the structural information of said engineered enzyme, as well as a first creation strategy, a second creation strategy, and a third creation strategy, obtaining a single-mutation variant set and a combinatorial-mutation variant set of said engineered enzyme. The present invention enables efficient and low-cost generation of single-mutation and combinatorial-mutation variant sets of an engineered enzyme to be modified, thereby achieving precise and efficient gene editing and effectively expanding the applicability and safety of gene editing.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

High-temperature-resistant cellobiose epimerase mutant and application thereof

The invention discloses a high-temperature-resistant cellobiose epimerase mutant and application thereof. The mutant is obtained by performing single mutation on the 242nd site of an amino acid sequence as shown in SEQ ID No.1. The invention also discloses a preparation method of the high-temperature-resistant cellobiose epimerase mutant. According to the invention, molecular modification is carried out on cellobiose epimerase (DiCE) from Dictyoglomus thermophilum, a mutant with improved thermal stability is screened out, the lactulose conversion efficiency of the obtained mutant is obviously improved, the mutant A242L can tolerate the temperature of 80 DEG C, the lactulose conversion rate is 64.41%, and the industrial application prospect is good.
Owner:ZHEJIANG UNIV OF TECH

L-threonine aldolase mutant and application thereof in synthesis of L-serine

The invention discloses an L-threonine aldolase mutant and application of the L-threonine aldolase mutant in synthesis of L-serine. The mutant is obtained by performing single mutation on the 88th amino acid of a wild type L-threonine aldolase amino acid sequence shown as SEQ ID No.2. The invention further discloses a preparation method of the L-threonine aldolase mutant. The invention provides the L-threonine aldolase mutant with better catalytic performance, aldol condensation reaction of formaldehyde and glycine can be efficiently catalyzed to prepare L-serine under the condition of not adding a tetrahydrofolic acid precursor, the yield of the L-serine is increased to 72.3% from 56.7% before mutation, the yield is remarkably increased, and the L-threonine aldolase mutant has the advantages that the L-threonine aldolase mutant has a good application prospect. Good application prospects are shown in the synthesis of the L-serine.
Owner:HENAN ZHONGYUAN YUZE BIOTECHNOLOGY CO LTD

5 '-phosphosulfate kinase mutant and application thereof

The invention relates to the technical field of enzyme catalysis, in particular to a 5 '-phosphosulfate kinase mutant and application thereof, and is characterized in that the 5'-phosphosulfate kinase mutant is obtained by performing single mutation or multiple mutation on an amino acid sequence as shown in SEQ ID NO: 1 and comprises one of the following mutation modes: (1) performing single mutation on the 66th site or 148th site of the amino acid sequence as shown in SEQ ID NO: 1; and (2) mutating the 66th site and 148th site of the amino acid sequence as shown in SEQ ID NO: 1 at the same time. Based on the design of the three-dimensional structure of the 5 '-phosphosulfate kinase, the 5'-phosphosulfate kinase mutant which can catalyze AMP to generate PAP and has obviously enhanced activity is obtained, the PAP activity of the 5 '-phosphosulfate kinase mutant with the highest activity is about 16 times that of a wild enzyme, and a solid foundation is laid for industrial production of 3'-adenosine-5 '-phosphosulfate.
Owner:杭州裕元生物科技有限公司 +1

Nitrilase mutant capable of reducing selectivity of 5-chloronicotinonitrile and improving selectivity of 6-chloronicotinonitrile and application of nitrilase mutant

PendingCN119120435Ahigh selectivityReduce catalytic activityBacteriaHydrolasesPtru catalystSingle mutation
The invention discloses a nitrilase mutant capable of reducing the selectivity of 5-chloronicotinonitrile and improving the selectivity of 6-chloronicotinonitrile and application of the nitrilase mutant. The nitrilase mutant is obtained by performing single mutation or multiple mutation on the 128 site, the 144 site and the 146 site of an amino acid sequence shown in SEQ ID No.2. The nitrilase mutant with obviously improved selectivity on 6-chloronicotinonitrile is obtained by screening, the 6-chloronicotinonitrile can be selectively catalyzed by taking recombinant cells containing nitrilase mutant genes or broken crude enzyme liquid of the recombinant cells as a catalyst and 6-chloronicotinonitrile and 5-chloronicotinonitrile as a common substrate, the high-purity 6-chloronicotinic acid can be synthesized in one step, the process is simple, the cost is low, and the method is suitable for industrial production. And the industrial cost is low. Compared with a wild type, the mutant has the advantages that the catalytic activity on 5-chloronicotinonitrile is reduced, and the selectivity on 6-chloronicotinonitrile is improved.
Owner:ZHEJIANG UNIV OF TECH

Tyrosine ammonia lyase mutant and application thereof in production of p-coumaric acid

The invention provides a tyrosine ammonia lyase mutant and application thereof in production of p-coumaric acid. The tyrosine ammonia lyase mutant is obtained by mutating wild type tyrosine ammonia lyase with an amino acid sequence as shown in SEQ ID No.1, and a mutation site is selected from at least one of Q108S, Y340Q and P375H. The catalytic activity center of wild type tyrosine ammonia lyase is analyzed, and site-directed mutagenesis is carried out on five catalytic activity center sites, so that the mutant shows different enzyme catalytic activity when the mutation sites are different, the mutation sites are the same but the mutation targets are different; q108S, Y340Q and P375H single mutations can significantly improve the enzyme catalytic activity of the tyrosine ammonia lyase mutant, and the tyrosine ammonia lyase mutant having any two mutation sites, especially having three mutation sites, also has better enzyme catalytic activity than the wild type, and has great application potential.
Owner:ZHEJIANG LVCHUANG BIOTECHNOLOGY CO LTD +2

A flavanone 3-hydroxylase mutant and its genetically engineered bacteria and application

The present invention discloses a flavanone 3-hydroxylase mutant and its genetic engineering bacteria and application, belonging to the field of genetic engineering and enzymology research. The flavanone 3-hydroxylase mutant is obtained by a single mutation of the 221st position of the flavanone 3-hydroxylase amino acid sequence to alanine, and the amino acid sequence is shown in SEQ ID NO.5. The present invention also provides a gene encoding the mutant and a recombinant engineering strain containing the gene; the mutant can increase the yield of dihydroquercetin, and the product content is 1.67 times that of the wild-type enzyme.
Owner:SOUTH CHINA UNIV OF TECH

Alcohol dehydrogenase mutant and application thereof in synthesis of symmetric chiral diol

The invention discloses an ethanol dehydrogenase mutant and an application of the ethanol dehydrogenase mutant in synthesis of symmetric chiral diol. The ethanol dehydrogenase mutant is obtained by carrying out single mutation or multiple mutations on amino acids at 74th, 187th, 210th, 211th and 352th sites of an ethanol dehydrogenase amino acid sequence as shown in SEQ ID NO.2 from Candida orbiculata Co. The invention further discloses a preparation method of the ethanol dehydrogenase mutant, and the preparation method comprises the following steps: carrying out single mutation or multiple mutations on the amino acids at the 74th, 187th, 210th, 211th and 352th sites of the ethanol dehydrogenase amino acid sequence as shown in SEQ ID NO.2. Alcohol dehydrogenase is utilized to catalyze prochiral symmetric diketone to synthesize symmetric chiral diol, the method is high in substrate concentration, high in stereoselectivity, mild in reaction, simple in operation process, environment-friendly and more suitable for industrial amplification production, and the problems that in the prior art, the substrate concentration is not high, the reaction condition is violent, the reaction process is complex and difficult to control, and the production cost is low are solved. And the method is not environment-friendly enough, and the like.
Owner:HANGZHOU WENDEJIE BIOTECHNOLOGY CO LTD

Lipase mutant, engineering bacterium and application of lipase mutant in preparation of (2S, 3R)-p-methylsulfonylphenylserine ethyl ester

The invention discloses a lipase mutant, an engineering bacterium and application of the lipase mutant in preparation of (2S, 3R)-p-methylsulfonylphenyl serine ethyl ester. The lipase mutant is obtained by performing single mutation or combined mutation on 67th, 115th or 400th amino acid of an amino acid sequence as shown in SEQ ID No.1. The invention further discloses a preparation method of the lipase mutant, the engineering bacterium and the application of the lipase mutant in preparation of (2S, 3R)-p-methylsulfonylphenyl serine ethyl ester. The lipase mutant provided by the invention has the advantages that the enzyme activity is obviously improved, the selectivity is not reduced, the reaction conversion rate of the lipase mutant serving as a catalyst reaches 50%, the required reaction time is obviously shortened by 1-7 hours, and the lipase mutant has more excellent catalytic activity. Under the optimal system, the conversion rate after 1000 mM of a substrate is split for 4 h reaches 50.5%, e.e.gt; therefore, a certain basis is provided for industrial preparation of optically pure (2S, 3R)-p-methylsulfonylphenyl serine ethyl ester.
Owner:ZHEJIANG UNIV OF TECH

Glycosidase mutant and application thereof in biosynthesis of hesperetin

The invention provides a glycosidase mutant and application thereof, the amino acid sequence of the mutant is compared with the amino acid sequence SEQ ID NO.1 of a wild enzyme, in the amino acid sequence SEQ ID NO.1, five sites of M102K, P171L, V203G, T269Y and K299D are respectively subjected to single mutation, pairwise combined mutation, three combined mutation, four combined mutation or one of five combined mutation; the novel glycosidase mutant industrial enzyme is used for synthesis and preparation of hesperetin. The glycosidase mutant enzyme constructed by the invention has the characteristics of low enzyme cost, short conversion time, simple process operation and the like, and has a wide prospect of large-scale industrial application.
Owner:GUANGDONG CHENYU BIOTECHNOLOGY CO LTD +1

Cellulase mutant and application thereof

The invention relates to the technical field of gene engineering and protein modification, in particular to a high-specific-activity cellulase mutant and application thereof. Compared with the wild type cellulase, the specific activity of the mutants respectively containing single mutation sites of P14A, P19T, S75A, S109N, H118P, M123I, M123L, I130L, I130Q, Y167E, Y167F, Y167W, A176S, A176F, D177S and L192I, provided by the invention, is generally improved by 10.4%-76.1% under a neutral condition. Wherein the specific activity of a single-site mutant containing I130L is the highest, and reaches 183.64 U / mg. The production cost of the cellulase mutant is remarkably reduced, so that wide application of the cellulase mutant is promoted.
Owner:QINGDAO VLAND BIOTECH GRP CO LTD

Cellulase mutants and use thereof

PCT designated stageWO2026097746A1FungiHydrolasesSingle mutationWild type
Provided are high-specific-activity cellulase mutants and use thereof. Compared to the wild-type cellulase, the specific activity of the provided mutants that comprise single mutation sites P14A, P19T, S75A, S109N, H118P, M123I, M123L, I130L, I130Q, Y167E, Y167F, Y167W, A176S, A176F, D177S, and L192I, respectively, under neutral conditions is generally increased by 10.4% to 76.1%. The single-point mutant comprising I130L has the highest specific activity, which reaches 183.64 U / mg. The production costs of the cellulase mutants are significantly lower, which facilitates the wide use thereof.
Owner:QINGDAO VLAND BIOTECH GRP CO LTD

A polyphosphoryl kinase mutant with high catalytic activity and its application in synthesis of glutathione

ActiveCN118931871BBacteriaTransferasesDouble mutationNucleotide
The present application relates to the technical field of bioengineering, and particularly relates to a polyphosphate kinase mutant with high catalytic activity and application thereof in synthesis of glutathione. The present application provides a polyphosphate kinase mutant with high catalytic activity, which is characterized in that the polyphosphate kinase mutant is mutated from an amino acid sequence shown in SEQ ID NO: 2 into one of the following: (1) single mutation is made to the 234th amino acid in the amino acid sequence shown in SEQ ID NO: 2; (2) double mutations are made to the 234th and 166th amino acids in the amino acid sequence shown in SEQ ID NO: 2; wherein a nucleotide sequence of a coding gene coding the amino acid sequence shown in SEQ ID NO: 2 is as shown in SEQ ID NO: 1. ch PPK-N234A and double-site mutation polyphosphate kinase mutant ch PPK-N234A / K166D has high activity, and the enzyme activity is increased by 4.19 times and 6.12 times, respectively, compared with wild-type polyphosphate kinase.
Owner:ZHEJIANG UNIV OF TECH

An RthB protein mutant and its application in isoleucine production

The present invention discloses an RthB protein mutant and its application in isoleucine production. The RthB protein mutant is obtained by performing single-site mutations or multi-site mutations at the 16th, 21st, 117th, and 156th positions of the amino acid sequence shown in SEQ ID NO:1. By mutating and modifying the RthB protein, the L-isoleucine fermentation yield of recombinant microorganisms expressing the mutant protein is increased, and the threonine content in the fermentation broth is decreased, thereby improving the yield and purity of isoleucine.
Owner:ANHUI HUAHENG BIOTECH CO LTD +1

L-aspartate aminotransferase mutant and its application

The present invention discloses an L-aspartate aminotransferase mutant and its application. The L-aspartate aminotransferase mutant is obtained by subjecting the amino acid at position 104 of the amino acid sequence of L-aspartate aminotransferase to a single mutation. The L-aspartate aminotransferase mutant is used to synthesize L-phenylglycine derivatives. The L-aspartate aminotransferase mutant is derived from Escherichia coli. After homologous sequence analysis and molecular docking simulation, combined with site-directed mutagenesis verification, a single-point mutation is performed on the amino acid at position 104 to obtain a T104S mutant. The L-aspartate aminotransferase mutant of the present invention can efficiently catalyze the production of L-phenylglycine derivatives. Compared with the wild type, the specific activity of the T104S mutant towards o-chlorophenoxyacetic acid is 3.2 times that of the wild type.
Owner:HEFEI UNIV OF TECH